[Hemocomponent therapy of central involution chorioretinal dystrophy]. / Gemokomponentnaia terapiia tsentral'noi involiutsionnoi khorioretinal'noi distrofii.

ABSTRACT

Hemocomponent therapy was used in 181 patients (347 eyes) with central chorioretinal dystrophy. Activated autoplasma possessing a marked resorptive effect, consisting in resorption of hemorrhages and exudations on the fundus oculi, was used. Vision acuity improved in 75% of examined eyes by an average of 0.2 diopters.